Salix Pharmaceuticals ("Salix"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, today announced that two RELISTOR® (methylnaltrexone bromide) scientific posters will be presented at the 46th Annual Regional Anesthesiology and Acute Pain Medicine Meeting being held May 13 – 15, 2021.
Link:
prnewswire.com/news-releases/salix-pharmacetuicals-will-present-scientific-data-featuring-post-hoc-analyses-for-relistor-methylnaltrexone-bromide-at-asras-46th-annual-spring-meeting-301291346.html
No comments:
Post a Comment